1. Side effects and compliance are important - that's old news.
2. Your point #2 is your opinion. The term "best" is not really appropriate for any current PI's anyway, as the regimen that a physician will recommend to a patient depends on many factors. In some instances, Viracept is appropriate, in others, Crix. It depends on the individual. In other instances, something other than triple-combination therapy can be chosen.
3. I do not disclose contacts to anyone.
4. Co-workers of mine/people I know who are/were HIV+ are dead. Others don't walk around telling me their HIV status, and it's none of my business, anyway. I guess you don't know any of the 30% of Viracept patients who get very unpleasant side effects, wheras the need to drink a lot of water if you taking the Merck drug seems to be an insurmountable hurdle. It's amusing in that generally people don't drink enough water anyway, especially since we drink coffee, tea, alcohol, which make our need for water even more important.
5. Having had 2 sell-side biotech analysts that do not follow AGPH on a formal basis, but who follow cancer closely who were at the last conference/seminar where Thymitaq results were presented tell me that they were unimpressed (& I'm being kind, here) is what I passed onto this thread.
6. On your personal profile, it says that you're affiliated with the US Congress. I now understand the saying, "Hi, I'm from the government and I'm here to help."
7. Please notice that I've toned down my verbage. I am now a kindler, gentler, warm and fuzzy kind of guy. In fact, by now, you probably wish that I were over for dinner or living as your neighbor - your property values would increase. I want you to know that I will soon be leaving your thread, in search of another area of obfuscation where my probing searchlight will illuminate the truth. I can only hope that the torch will be taken by another eagle-scount in search of truth, justice, & the American way. I would though, really like to attend the world premiere of Godzilla in April, 98. Can you get me tickets?
Finally, if you are aware, & I am serious about this, of other biotech firms where you think reality is quite different than public perception, do let me know. My investigative resources are quite extensive, and although I can't chase every story down, if I find something amiss, I will post it on the appropriate thread.
Regarding AGPH as a stock, it will be quite volatile due to a high short interest, news breaking on work by other drug companies, etc. |
